HYPOTHESIS: Limiting spatial overlap between electrical stimulation (ES) and acoustical stimulation (AS) in the cochlea reduces the effects of AS on electrically evoked auditory nerve activity. BACKGROUND: Some hybrid cochlear implant systems have a regular array, whereas others have short arrays that spatially segregate ES from AS. AS settings in hybrid implants may also affect electroacoustic interaction. METHODS: ES (900 μA) was delivered in the high-frequency part of the cochlea, and the electrically evoked compound action potential (eCAP) was recorded to assess auditory nerve activity. Maximal spatial overlap of ES and AS was tested by using normal-hearing animals (NH, n = 6), whereas minimal overlap was modeled by using animals with high-frequency hearing loss (HFHL, n = 6). AS consisted of broadband (BB) or low-frequency (LF) noise (0-100 dB SPL). Effects of AS on eCAP amplitude were statistically tested using 1-sample t tests (α = 0.05). RESULTS: BB noise at 60 dB SPL significantly suppressed eCAP amplitude in NH animals but not in HFHL animals up to a 30 dB higher level. Suppression with LF noise at 60 dB SPL was not significant in either the NH or the HFHL group, but at 90 dB SPL, suppression was significant in both groups. CONCLUSION: Minimizing spatial overlap between ES and AS reduces eCAP suppression when moderate sound levels are applied. Overlap can be reduced by applying ES in an acoustically insensitive part of the cochlea or by limiting the acoustic spectrum to low frequencies when ES is applied in acoustically sensitive areas.
, and animals with high-frequency hearing loss (HFHL, n = 6). CAP threshold shifts were determined with respect to NH before the cochleostomy (indicated by the horizontal dashed line). The mean audiogram of NH, therefore, shows the effect of drilling the cochleostomy and placement of the stimulation electrode in the basal turn. The audiograms of the HFHL animals show the effect of ototoxic treatment combined with the surgical procedures. B and C, Relative frequency spectrum of broadband and low-frequency noise. Overall sound level was 80 dB SPL, and 0 dB corresponds to the peak in the spectrum. The approximate stimulation electrode position in terms of characteristic frequency was around 30 kHz (arrows).
FIG. 2.
Cartoon showing the electrical forward masking paradigm described by Miller et al. (19) . By applying a probe pulse, the eCAP can be measured (probe). The stimulus artifact is removed by mathematical subtraction of a masker and probe stimulus (masker + probe). The masker eliminates the probe response when the masker-probe interval is sufficiently short, allowing probe artifact elimination without losing the eCAP signal. Last, the introduced masker pulse artifact is removed by mathematically adding a masker only response. Hence, 3 recordings are necessary for 1 decontaminated eCAP response. The interval between masker pulse and probe pulse in our experiments was 0.7 ms. Masker and probe were fixed at 900 uA. FIG. 4. Differences in absolute eCAP amplitudes evoked at 900 uA in normal-hearing animals (NH) and animals with a high-frequency hearing loss (HFHL). A, Example eCAP waveform in a NH animal. The first negative and positive peak was used to determine eCAP amplitude (N1 and P1). B, Example eCAP waveform in a HFHL animal. eCAP amplitude A is indicated. A second negative eCAP peak can be seen, followed by a third long-latency electrophonic peak. N1 latency was approximately 0.3 ms. C, Absolute eCAP amplitudes in the NH animals (n = 6, mean: 116 uV) and HFHL animals (n = 6, mean: 391 uV) differed significantly (2-sample, 2-tailed t-test, t10 = 2.29, p < 0.05). 
